D Liénard

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

Michael Hahne, Donata Rimoldi, Michael Schröter et al. · Science · 1996 · 1.3K citations

Life Sciences, Immunology, Oncology +17

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.

D Liénard, Patricia Ewalenko, Jean-Baptiste Delmotte et al. · Journal of Clinical Oncology · 1992 · 723 citations

Pharmacy, Oncology, Pharmacotherapy +17

Selective Accumulation of Mature DC-Lamp+ Dendritic Cells in Tumor Sites Is Associated with Efficient T-Cell-Mediated Antitumor Response and Control of Metastatic Dissemination in Melanoma

Mojgan Movassagh, Alan Spatz, Jean Davoust et al. · Cancer Research · 2004 · 106 citations

Life Sciences, Immunology, Oncology +17

Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma.

Danila Valmori, Valérie Dutoit, Verena Rubio‐Godoy et al. · PubMed · 2001 · 72 citations

Life Sciences, Immunology, Oncology +17

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.

Danila Valmori, Mikaël J. Pittet, Cédric Vonarbourg et al. · PubMed · 1999 · 68 citations

Life Sciences, Immunology, Oncology +17